MCM
GDRX icon

Moore Capital Management’s GoodRx Holdings GDRX Stock Holding History

Moore Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3M Buy
1,529,415
+590,851
+63% +$1.39M 0.06% 224
2025
Q4 		$2.54M Buy
938,564
+414,513
+79% +$1.36M 0.04% 344
2025
Q3 		$2.22M Buy
+524,051
New +$2.3M 0.03% 346
2025
Q1 		– Sell
-237,892
Closed -$1.11M – 539
2024
Q4 		$1.11M Buy
+237,892
New +$1.31M 0.01% 366

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Moore Capital Management's GDRX Position: Q1 2026 in Review

Moore Capital Management increased its GoodRx Holdings (GDRX) stake by 63% in Q1 2026, buying an estimated $1.39M and bringing the position to 1,529,415 shares worth $3M. The position accounts for 0.06% of the portfolio, ranked #224.

Moore Capital Management first reported a position in GDRX in Q4 2024 and has held it in 4 quarters since. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Moore Capital Management held 1,529,415 shares of GoodRx Holdings worth $3M as of Q1 2026.
  • Moore Capital Management bought 590,851 GoodRx Holdings shares in Q1 2026, an estimated $1.39M.
  • GoodRx Holdings made up 0.06% of Moore Capital Management's portfolio in Q1 2026, its #224 holding.
  • Moore Capital Management first reported a position in GoodRx Holdings in Q4 2024 and has held it in 4 quarters since.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.